Health Care/Hospital

China Medicine Announces First Quarter 2007 Results

First Quarter and Recent Highlights: -- Revenue increased 34% to $5.1 million -- Operating income increased 102% to $0.9 million -- Net Income increased 162% to $0.8 million or $0.06 per diluted share -- Company strengthens balance sheet through the receipt of ...

2007-05-17 11:00 558

China Biopharmaceuticals Holdings Announces First Quarter 2007 Financial Results

BEIJING, May 16 /Xinhua-PRNewswire-FirstCall/ -- -- Net Sales Increase 36% to $7.5 million for Q1 2007 -- Income from Operations Increase 39% to $640,364 China Biopharmaceuticals Holdings, Inc. (OTC Bulletin Board: CHBP), a leading Chinese pharmaceutical company focused on t...

2007-05-16 23:41 641

Winner Medical Group Reports Second Quarter Fiscal 2007 Results

SHENZHEN, China, May 15 /Xinhua-PRNewswire/ -- Winner Medical Group Inc. (OTC Bulletin Board: WMDG), today reported financial results for the second quarter of fiscal year 2007, ending March 31, 2007. Consolidated sales for the second fiscal quarter were approximately $15.1 million com...

2007-05-16 20:30 715

Simcere Pharmaceutical Group Reports First Quarter 2007 Results

First Quarter 2007 Net Income Increased 155.6% Year-over-Year NANJING, China, May 16 /Xinhua-PRNewswire/ -- Simcere Pharmaceutical Group (NYSE: SCR), a leading manufacturer and supplier of branded generic pharmaceuticals in China, today reported unaudited financial results for the first ...

2007-05-16 06:00 558

China Pharma Holdings, Inc. Announces First Quarter 2007 Results

HAIKOU CITY, Hainan Province, China, May 15 /Xinhua-PRNewswire-FirstCall/ -- China Pharma Holdings, Inc. (“China Pharma”) (OTC Bulletin Board: CPHI), a specialty bio-pharmaceutical company that develops, manufactures and markets Western and Chinese medicines, today announced its financial re...

2007-05-15 20:00 930

First Patient Enrols in Aridol COPD Trial

SYDNEY, Australia, May 15 /Xinhua-PRNewswire-FirstCall/ -- Pharmaxis (ASX: PXS; Nasdaq: PXSL) today announced that the first patients have been enrolled in a Swiss clinical trial evaluating the ability of Aridol to predict the response to inhaled steroids in patients with Chronic Obstructive...

2007-05-15 21:00 657

Mindray Medical International Announces First Quarter 2007 Results

First Quarter 2007 Net Income Grows 79% Year-Over-Year SHENZHEN, China, May 14 /Xinhua-PRNewswire-FirstCall/ -- Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices in China with a rapidly growing international presence, today a...

2007-05-15 05:00 690

Mylan Laboratories to Acquire Generics Business of Merck KGaA

-- Combination Creates a World Class Global Generics Leader -- Significant Scale and Breadth Will Drive Major Operating Efficiencies -- Highly Complementary Transaction Further Strengthens Mylan's Product Portfolio -- Accelerates Mylan's Revenue and Earnings Growth -- Anticipated to be...

2007-05-14 16:40 819

Nick Colucci Named President and CEO of Publicis Healthcare Communications Group

Appointment Marks Culmination of 3-year Succession Plan NEW YORK, May 14 /Xinhua-PRNewswire/ -- Nick Colucci has been appointed President and CEO of Publicis Healthcare Communications Group (NYSE: PUB), replacing Ed Rady, his mentor and colleague for the past 11 years. Mr. Rady, who ha...

2007-05-14 09:20 1586

China Pharma Holdings, Inc. Announces Conference Call to Discuss First Quarter 2007 Results

HAIKOU CITY, Hainan Province, China, May 10 /Xinhua-PRNewswire/ -- China Pharma Holdings, Inc. ("China Pharma") (OTC Bulletin Board: CPHI) today announced that the Company will host a conference call at 10:00 am ET on Tuesday, May 15, 2007, to discuss results for the first quarter of 2007. ...

2007-05-10 23:42 876

China Holdings, Inc. to Present at 3rd China Healthcare Industry Business Opportunity Trade Conference

LAS VEGAS, May 10 /Xinhua-PRNewswire-FirstCall/ -- China Holdings, Inc. (OTC Bulletin Board: CHHH), a global holding company and its subsidiaries engage in multiple China-focused business activities including pharmaceutical, real estate, utilities, energy and finance, today announced that the ...

2007-05-10 22:48 616

Sinovac Commences Phase II Clinical Trials for Pandemic Influenza Vaccine (H5N1)

BEIJING, May 9 /Xinhua-PRNewswire/ -- Sinovac Biotech Ltd. (Amex: SVA), a leading provider of biopharmaceutical products in China, today announced that the China State Food and Drug Administration (SFDA) recently granted Sinovac approval to commence the Phase II clinical trial of Panflu(TM), a...

2007-05-09 20:38 751

China Health Holding, Inc. Changes Name to China Holdings, Inc.

LAS VEGAS, May 9 /Xinhua-PRNewswire-FirstCall/ -- China Health Holding, Inc. (OTC Bulletin Board: CHHH), a development stage company targeting to become a leading developer, manufacturer, marketer and distributor of pharmaceutical drugs and dietary supplements in China and worldwide, announced...

2007-05-09 21:48 746

Singapore Continues to Attract Top Scientific Talents

Offers Investigatorship Awards up to US$500,000 to Outstanding Young Scientists of all Nationalities to Undertake Independent Research in Singapore BOSTON, May 9 /Xinhua-PRNewswire/ -- Singapore continues to thrive as a vibrant location for scientific talent. Significant efforts and resource...

2007-05-09 21:00 773

New Regulatory Team at Quintiles Helps Bring Biotechnology Products to Market

Former FDA, Industry Experts Have More Than 115 Years of Experience RESEARCH TRIANGLE PARK, N.C., May 8 /Xinhua-PRNewswire/ -- Quintiles Transnational Corp. today announced the formation of a global biologics regulatory team to advise customers about development plans and optimal strategy f...

2007-05-09 09:02 787

Singapore Attracts Four Major Biologics Manufacturing Investments Totaling Close to US$1 Billion in Less Than Two Years

BOSTON, May 8 /Xinhua-PRNewswire/ -- Having established a reputation as the most competitive and trusted site for pharmaceutical bulk activities and secondary manufacturing, Singapore is now aggressively pursuing investments in biologics (Note 1), an area that will drive growth in the drug indus...

2007-05-09 03:30 683

China Biopharmaceuticals Names New Officer and Directors

Ms. Zhang Jian named Chairwoman of the Board Mr. Shi Mingsheng appointed Chief Operating Officer Mr. Ding Weihua appointed to the Board of Directors BEIJING, May 7 /Xinhua-PRNewswire-FirstCall/ -- China Biopharmaceuticals Holdings, Inc. (OTC Bulletin Board: CHBP), a leading pharmaceutic...

2007-05-08 10:21 587

3SBio Inc. to Present at the UBS Global Generic and Specialty Pharmaceuticals Conference and the Merrill Lynch Pan Asia Rising Stars Conference

SHENYANG, China, May 7 /Xinhua-PRNewswire-FirstCall/ -- 3SBio Inc. (Nasdaq: SSRX), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, will present at the UBS Global Generic and Specialty Pharmaceuticals Conferen...

2007-05-08 09:59 809

World's Leading Pharmaceutical Companies Make Significant Expansions to Their Corporate Research Laboratories in Singapore

Continued Growth is a Strong Endorsement of Singapore as a Location for Drug Discovery & Development BOSTON, May 7 /Xinhua-PRNewswire/ -- Singapore's position as a location for cutting-edge research and development (R&D) was further validated when leading drug makers Lilly, GlaxoSmithKline ...

2007-05-07 21:00 630

Protelos(R): First Osteoporosis Treatment to Show Long-Term, Sustained Efficacy and Quality of Life Improvement

-- New Data Show Clear Benefit of Protelos(R) in Wide Range of Osteoporosis Patients Irrespective of Disease Severity COPENHAGEN, Denmark, May 7 /Xinhua-PRNewswire/ -- New, long term data presented at the 34th European Symposium on Calcified Tissues (ECTS) this week underscore the unma...

2007-05-07 16:17 818
1 ... 746747748749750751752 ... 758